Differences in disease prevalence as a source of the U.S.-European health care spending gap.
暂无分享,去创建一个
Katya Galactionova | K. Thorpe | D. Howard | Kenneth E Thorpe | David H Howard | Katya Galactionova | K. Galactionova
[1] T. Vanitallie. Prevalence of obesity. , 1996, Endocrinology and metabolism clinics of North America.
[2] H. Hense,et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. , 2003, JAMA.
[3] James H. Bigelow,et al. Analysis of Healthcare Interventions that Change Patient Trajectories , 2005 .
[4] K. Flegal,et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. , 2005, JAMA.
[5] U. Reinhardt,et al. It's the prices, stupid: why the United States is so different from other countries. , 2003, Health affairs.
[6] J. Newhouse. Commentary on Getzen's ''Aggregation and the Measurement of Health Care Costs'' , 2006 .
[7] Zoe Oldfield,et al. Disease and disadvantage in the United States and in England. , 2006, JAMA.
[8] G. Colditz,et al. The disease burden associated with overweight and obesity. , 1999, JAMA.
[9] E. Berndt,et al. The value of antihypertensive drugs: a perspective on medical innovation. , 2007, Health affairs.
[10] A. Mokdad,et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.
[11] Gerard F Anderson,et al. U.S. health care spending in an international context. , 2004, Health affairs.
[12] K. Thorpe,et al. The rising prevalence of treated disease: effects on private health insurance spending. , 2005, Health affairs.
[13] Quinn Mj. Cancer Trends in the United States—A View From Europe , 2003 .
[14] K. Thorpe. The rise in health care spending and what to do about it. , 2005, Health affairs.